Elisabeth Sonesson

Imlifidase Desensitization in Crossmatch-positive, Highly Sensitized Kidney Transplant Recipients: Results of an International Phase 2 Trial (Highdes)

Stanley C. Jordan, Christophe Legendre, Niraj M. Desai et al. · Transplantation · 2020 · 106 citations · Full text

Endopeptidase Cleavage of Anti-Glomerular Basement Membrane Antibodies in vivo in Severe Kidney Disease: An Open-Label Phase 2a Study

Fredrik Uhlin, Wladimir Szpirt, Andreas Kronbichler et al. · Journal of the American Society of Nephrology · 2022 · 61 citations · Full text

A single-arm, open-label, phase 2 clinical trial evaluating disease response following treatment with BI-505, a human anti-intercellular adhesion molecule-1 monoclonal antibody, in patients with smoldering multiple myeloma

Stina Wichert, Gunnar Juliusson, Åsa Johansson et al. · PLoS ONE · 2017 · 51 citations · Full text

A Phase I Dose-Escalation Study of Antibody BI-505 in Relapsed/Refractory Multiple Myeloma

Markus Hansson, Peter Gimsing, Ashraf Badros et al. · Clinical Cancer Research · 2015 · 49 citations · Full text

The IgG-degrading enzyme of Streptococcus pyogenes causes rapid clearance of anti-glomerular basement membrane antibodies in patients with refractory anti-glomerular basement membrane disease

Inga Soveri, Johan Mölne, Fredrik Uhlin et al. · Kidney International · 2019 · 46 citations

Glomerulonephritis, Autoimmune Disease, Medicine +9